The remodelling of heart chambers in elderly patients after coronary artery bypass graft which were treated by lipid lowering drugs

We present the dynamics of morphological and functional heart disorders in elderly patients undergoing coronary bypass surgery within 1 year of lipid lowering therapy. In patients of group 1 treated with high dose of rosuvastatin (20 mg daily) and group 2 treated with atorvastatin 40 mg daily with dose escalation and possible addition of ezetimibe 10 mg daily to achieve the target level of LDL or ≥50% of its initial level decreasing we observed the reduction of heart chambers remodeling and increasing of patients exercise tolerance. In patients of group 3 who received moderate dose of simvastatin (40 mg daily) we revealed morphological and functional heart disorders stabilization and exercise tolerance increasing.